openPR Logo
Press release

Thyroid Eye Disease Market Report on the Untapped Growth Opportunities in the Industry

Thyroid Eye Disease Market Report on the Untapped Growth

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Thyroid Eye Disease Market - (By Marketed Treatment (TEPEZZA (Teprotumumab), By Pipeline Treatment (VRDN 001, VB 421, Batoclimab, Linsitnib)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."

According to the latest research by InsightAce Analytic, the Thyroid Eye Disease Market is valued at US$ 2.15 billion in 2023, and it is expected to reach US$ 3.31 billion by 2031, with a CAGR of 5.7% during the forecast period of 2024-2031.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2893

Thyroid eye disease (TED), also known as Graves' orbitopathy or Graves' ophthalmopathy, is an autoimmune disorder characterized by inflammation and swelling around the eyes. The increasing prevalence of thyroid eye disease is expected to drive market growth in the coming years. Additionally, enhanced healthcare infrastructure, improved patient compliance rates, and advancements in autoimmune disease treatments are key factors contributing to market expansion.

Furthermore, the global thyroid eye disease market is poised to offer significant revenue-generating opportunities for industry participants, driven by rising disposable income levels and ongoing research and development (R&D) initiatives. Substantial investments by leading market players, coupled with technological advancements in treatment solutions, have created lucrative growth prospects for manufacturers and suppliers operating in the thyroid eye disease sector.

List of Prominent Players in the Thyroid Eye Disease Market:
• Horizon Therapeutics
• Viridian Therapeutics
• Pierre Fabre/ACELYRIN
• HanAll Biopharma/Harbour BioMed/Immunovant
• Sling Therapeutics
• Other Market Players

Market Dynamics:
Drivers-
The increasing prevalence of thyroid eye disease (TED) is a primary factor expected to drive market growth. Additionally, enhanced patient compliance, advancements in autoimmune disease treatments, and rising investments in research and development (R&D) are contributing significantly to market expansion. The growing focus on therapeutic innovations and improved treatment accessibility is further anticipated to bolster the global thyroid eye disease market.

Curious About This Latest Version Of The Report? Enquiry Before Buying:
https://www.insightaceanalytic.com/enquiry-before-buying/2893

Challenges:
A lack of definitive treatment options and limited awareness in emerging economies are key challenges that may hinder market growth. Additionally, the high cost of treatment is expected to act as a barrier to widespread adoption. The COVID-19 pandemic has further disrupted market dynamics, leading to global supply chain interruptions, economic losses for key industry players, and halted production activities. These disruptions have impacted distributors, suppliers, and retailers, creating challenges for market expansion.

Regional Trends:
North America is projected to dominate the thyroid eye disease market, driven by high disease prevalence, advancements in treatment solutions, and robust R&D investments by key industry players. The region is expected to maintain a strong compound annual growth rate (CAGR) in the coming years. Europe also holds a significant market share, supported by a well-developed healthcare infrastructure and increasing adoption of innovative treatment strategies. The presence of leading market participants and collaborative initiatives aimed at expanding market penetration further strengthens the region's market position.

Recent Developments:
• In March 2024, ACELYRIN, INC. announced positive proof-of-concept results from a Phase 1⁄2 trial of lonigutamab in thyroid eye condition that is now underway. Lonigutamab is a subcutaneous (SC) humanized IgG1 monoclonal antibody that aims the insulin-like growth factor-1 receptor (IGF-1R), a known mechanism of action for thyroid eye disease treatment.

Unlock Your GTM Strategy:
https://www.insightaceanalytic.com/customisation/2893

Segmentation of Thyroid Eye Disease Market-
By Marketed Treatment-
• TEPEZZA (Teprotumumab)
By Pipeline Treatment-
• VRDN 001
• VB 421
• Batoclimab
• Linsitnib
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

Get more information:
https://www.insightaceanalytic.com/report/thyroid-eye-disease-market/2893

Contact us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.JPG

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Thyroid Eye Disease Market Report on the Untapped Growth Opportunities in the Industry here

News-ID: 3939597 • Views:

More Releases from Insightace Analytic Pvt Ltd.

4PL Logistics Market Revenue Report with Forecast to 2034
4PL Logistics Market Revenue Report with Forecast to 2034
"4PL Logistics Market" in terms of revenue was estimated to be worth $59.6 Billion in 2024 and is poised to reach $133.3 Billion by 2034, growing at a CAGR of 8.5% from 2025 to 2034 according to a new report by InsightAce Analytic. Get Free Sample Report @ https://www.insightaceanalytic.com/request-sample/1609 Latest Drivers Restraint and Opportunities Market Snapshot: Key factors influencing the global 4PL Logistics Market are: • Rapid growth of automotive the
Heavy-Duty Autonomous Vehicle Market Exclusive Trends Analysis with Forecast to 2034
Heavy-Duty Autonomous Vehicle Market Exclusive Trends Analysis with Forecast to …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Heavy-Duty Autonomous Vehicle Market- (By Application (Logistics, Public Transportation, Construction and Mining, Others), By Propulsion Type (Internal Combustion Engine Vehicles, Electric Vehicles), By Vehicle Type (Heavy Trucks, Heavy Buses, Roboshuttles), By Level of Autonomy (Fully Autonomous Vehicles, Semi-Autonomous Vehicles), By Sensor Type (LiDAR, RADAR, Camera, Others)) Trends, Industry Competition Analysis, Revenue and Forecast To 2034." According
E-Commerce Logistics Market Exclusive Report with Detailed Study Analysis
E-Commerce Logistics Market Exclusive Report with Detailed Study Analysis
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global E-Commerce Logistics Market Size, Share & Trends Analysis Report By Service Type (Transportation And Warehousing) And Operational Area (International And Domestic)- Market Outlook And Industry Analysis 2034" The global e-commerce logistics market is estimated to reach over USD 5340.2 billion by 2034, exhibiting a CAGR of 26.4% during the forecast period. Request For Free Sample Pages:
E-bikes Market Exclusive Report on the Latest Revenue and Future Scope
E-bikes Market Exclusive Report on the Latest Revenue and Future Scope
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global E-bikes Market Size, Share & Trends Analysis Report By Class (Class-I, Class-II, Class-III), Speed (Up to 25km/h, 25-45 km/h), Battery Type (Lithium-ion, Lithium-ion Polymer, Lead Acid), Mode (Pedal Assist, Throttle), Component (batteries, electric motors, frames with forks, wheels, crank gears, brake systems and motor controllers) , Motor Type (hub and mid), Usage (mountain, trekking, city/urban,

All 5 Releases


More Releases for Thyroid

Rising Incidences of Thyroid Disorders Fuel Growth In The Thyroid Function Test …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Thyroid Function Test Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market size for thyroid function tests has witnessed substantial growth in the past few years. The market is projected to expand from $1.7 billion in 2024 to $1.81 billion in 2025, with an
Rising Incidences of Thyroid Disorders Fuel Growth In The Thyroid Function Test …
The Thyroid Function Test Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Thyroid Function Test Market Size During the Forecast Period? The thyroid function test market has grown significantly in recent years. It is expected to grow from $1.7 billion in 2024
Thyroid Function Test Market Report 2024 - Thyroid Function Test Market Growth A …
"The Business Research Company recently released a comprehensive report on the Global Thyroid Function Test Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. Ready to Dive into Something Exciting? Get Your Free Exclusive
Thyroid Ablation Devices Market
Alarming rise in prevalence of thyroid cancer, advancements in thyroid ablation system, rise in government & private funds for development of healthcare sectors, and increase in number of thyroid nodule cases are expected to notably contribute toward the growth of the global thyroid ablation devices market during the forecast period. Rise in prevalence of thyroid cancer and thyroid nodules, demand for minimally invasive procedures, and technological advancements in ablation devices drive
Thyroid Gland Disorders Treatment Market Increasing incidence of Autoimmune Dise …
The global market for thyroid gland disorders features a consolidated vendor landscape with a handful of companies accounting for a major chunk of the global market, observes Transparency Market Research in a recent report. In 2016, the thyroid gland disorders treatment market was dominated by Merck KGaA and AbbVie, Inc., which collectively accounted for more than half of the market. It has been observed that despite the large pool of
Increasing Incidence of Thyroid Gland Disorders Expected to Propel the Thyroid G …
Thyroid gland is made of thyroid cells that absorb iodine from food and convert it into triiodothyronine (T3) and thyroxine (T4). These hormones are released into the blood stream and play an important role in the regulation of metabolism. Thyroid gland disorders are defined as an abnormal release of thyroid hormones which may demand proper therapeutic agents to correct the disorder condition. This report studies the market in a view